Status:

UNKNOWN

The CYBERnetic LowEr Imb coGnitive Ortho-prostheis Plus Plus, 2nd Clinical Study (CLs++)

Lead Sponsor:

Vrije Universiteit Brussel

Collaborating Sponsors:

Össur Iceland ehf

University of Ljubljana

Conditions:

Lower Limb Amputation Above Knee (Injury)

Eligibility:

All Genders

18-80 years

Phase:

NA

Brief Summary

The aim of the project is to evaluate the efficacy of the Cyberlegs X-leg in people with a unilateral transfemoral (above the knee joint) and transtibial (under the knee joint) amputation. De Cyberleg...

Detailed Description

Study design A crossover study and a case study design. Subjects Number of subjects 14 participants will be recruited for this study. Inclusion criteria Age:18 - 80 year Gender: men and women Level ...

Eligibility Criteria

Inclusion

  • Level of amputation: unilateral transfemoral or transtibial
  • Completed the rehabilitation program
  • Functional Medicare Classification K-level 2-4

Exclusion

  • Comorbidity (hemiplegia or neurological diseases)
  • Stump pain or bad fit of the socket

Key Trial Info

Start Date :

January 2 2020

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 31 2020

Estimated Enrollment :

14 Patients enrolled

Trial Details

Trial ID

NCT04129853

Start Date

January 2 2020

End Date

December 31 2020

Last Update

May 28 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Vrije Universiteit Brussel

Brussels, Belgium, 1050

The CYBERnetic LowEr Imb coGnitive Ortho-prostheis Plus Plus, 2nd Clinical Study (CLs++) | DecenTrialz